当前位置: X-MOL 学术Nat. Biotechnol. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
The clinical cutting edge.
Nature Biotechnology ( IF 33.1 ) Pub Date : 2020-07-08 , DOI: 10.1038/s41587-020-0612-2


As CRISPR–Cas9 enters human testing, the blistering pace of progress in preclinical research is offering a bewildering array of options for therapeutic gene editing.

中文翻译:

临床前沿。

随着CRISPR–Cas9进入人体测试,临床前研究的飞速发展为治疗性基因编辑提供了令人困惑的选择。
更新日期:2020-07-08
down
wechat
bug